Selected article for: "active fever and acute respiratory syndrome"
Author: Zhao, Chun-Hong; Wu, Hui-Tao; Che, He-Bin; Song, Ya-Nan; Zhao, Yu-Zhuo; Li, Kai-Yuan; Xiao, Hong-Ju; Zhai, Yong-Zhi; Liu, Xin; Lu, Hong-Xi; Li, Tan-Shi
Title: Prediction of fatal adverse prognosis in patients with fever-related diseases based on machine learning: A retrospective study
  • Document date: 2020_3_5
    • ID: tk3861u0_21
    Snippet: Troponin T is one of the clinically recognized markers to reflect myocardial injury. When its level increases, it can reflect the increased severity of myocardial injury, with high specificity. [13] [14] [15] Previous studies have suggested that myocardial injury, as reflected by elevated cardiac troponin levels in plasma, is common in patients with community-acquired pneumonia. [16] The main reason for poor prognosis in patients with severe seps.....
    Document: Troponin T is one of the clinically recognized markers to reflect myocardial injury. When its level increases, it can reflect the increased severity of myocardial injury, with high specificity. [13] [14] [15] Previous studies have suggested that myocardial injury, as reflected by elevated cardiac troponin levels in plasma, is common in patients with community-acquired pneumonia. [16] The main reason for poor prognosis in patients with severe sepsis is that patients often have cardiac dysfunction. Once the cardiovascular system is damaged, the death rate of patients increases greatly. [17] In this study, ALB was found to be a key factor in predicting the death or poor prognosis in patients with fever. Hoeboer et al [18] concluded that ALB rather than Creactive protein may be valuable in predicting and monitoring the severity and course of acute respiratory distress syndrome in critically ill patients with or at risk for the syndrome after new onset fever. Therefore, active correction of hypoproteinemia in patients with fever may improve prognosis.

    Search related documents:
    Co phrase search for related documents
    • cardiac dysfunction and death rate: 1
    • cardiac dysfunction and distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37
    • cardiac dysfunction and elevated plasma cardiac troponin level: 1
    • cardiac dysfunction and fever patient: 1, 2
    • cardiac dysfunction and high specificity: 1, 2
    • cardiac dysfunction and increase severity: 1
    • cardiac dysfunction and key factor: 1
    • cardiac dysfunction and level increase: 1
    • cardiac dysfunction and myocardial injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37
    • cardiac dysfunction and onset fever: 1
    • cardiac dysfunction and plasma cardiac troponin level: 1
    • cardiac dysfunction and poor prognosis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • cardiac dysfunction and poor prognosis death: 1
    • cardiac dysfunction and previous study: 1
    • cardiac dysfunction and prognosis improve: 1
    • cardiac dysfunction and severe sepsis: 1, 2, 3, 4, 5, 6, 7
    • cardiac dysfunction and severe sepsis patient: 1, 2
    • cardiac dysfunction and syndrome risk: 1, 2, 3, 4
    • cardiac troponin and Creactive protein: 1, 2, 3, 4